Stop GCT, Ovarian Cancer Research Foundation

Stop GCT, Ovarian Cancer Research Foundation Fighting Granulosa Cell Tumor Ovarian Cancer with Information, Advocacy, Community, and Research. Follow us on Twitter, LinkedIn, and Instagram @ stopgct.

Today is an important day! Amit Johal, family and friends are going to climb Mt. Snowdon in Wales to celebrate the life ...
06/24/2023

Today is an important day! Amit Johal, family and friends are going to climb Mt. Snowdon in Wales to celebrate the life of his wife, Raj. She passed away last December from Granulosa Cell Tumor Ovarian Cancer. StopGCT is allocating $5000 for this cause (specifically for GCT) and will be ascending Mt. Hamilton in the SF Bay Area at sunrise in honor of Raj.

Please support Raj's cause at Ovacome - The Ovarian Cancer Support Charity. See the following link:

Raj fought valiantly with a rare form of ovarian cancer, Granulosa Cell Tumor (GCT). GCT is usually slow growing, however Raj’s was very aggressive and despite numerous surgeries, multiple different chemotherapy treatments and radiotherapy, Raj sadly passed away 18 months after her diagnosis. Raj ...

Ministerio de Sanidad  ¿Cuál es el mejor punto de contacto para los pacientes con Cáncer de Ovario de Tumor de Células d...
10/08/2020

Ministerio de Sanidad ¿Cuál es el mejor punto de contacto para los pacientes con Cáncer de Ovario de Tumor de Células de la Granulosa para obtener pruebas regulares de biomarcadores: Inhibina A, Inhibina B y AMH? Póngase en contacto con StopGCT para ayudar a resolver un problema de monitorización de una paciente de TCG en España. ¡Gracias! -> stopgct @ gmail

  was a cancer survivor and dissented and fought to influence US   policy, patient rights and  . She was a champion of w...
09/28/2020

was a cancer survivor and dissented and fought to influence US policy, patient rights and . She was a champion of women everywhere, supported the within the larger framework of the law, served on the for 27 years, and was a singular legal mind that can never be replaced. celebrates her life and altruism and shares in her strong dedication to . Her legacy will continue to shine brightly and be a beacon to all of us long into the future.

BE INFORMED! September is   month!   is a rare, hormonally-active, malignant, sex-cord stromal form of   that accounts f...
09/01/2020

BE INFORMED! September is month! is a rare, hormonally-active, malignant, sex-cord stromal form of that accounts for 2-5% of all ovarian cancers and may be lethal in advanced cases.

Persistent signs and symptoms of GCT may include (varying combinations): excessive/post-menopausal bleeding (with elevated uterine cancer risk) or extended/disrupted/absent me**es, bloating/water retention (possibly with ongoing breast tenderness and elevated breast cancer risk), precocious puberty (young girls), possible aggravation of endometriosis, hirsutism, and/or PCOS-like symptoms, changes in bathroom habits (including constipation and/or frequent urination), fatigue/cognitive symptoms, and pelvic, back and/or abdominal pain.

Note that the commonly-used CA125 test is NOT usually diagnostic in GCT and should NEVER be used as a single test to rule out the presence of this rare if the result is negative. Relevant tests to help diagnose possible GCT may include: Inhibin A, Inhibin B, AMH/MIS, Estradiol, FSH, LH and imaging.

Importantly, if you have persistent symptoms, as above, ask to see a Gynecologic Oncologist. OB/GYN Trans-Vaginal Ultrasound (TVU) is often the first point of detection for ovarian cysts, many of which may be benign. However, for optimal diagnosis and care in the presence of possible GCT or other ovarian cancer, see a GYN/ONC. Do not allow an OB/GYN to perform a cystectomy of your ovarian cyst of *unknown origin* until you speak with a specialist.

Do you have questions about ovarian GCT? Do you need help with information and advocacy? If so, send us a message! We're here to help!

Note: If you are and retain your ovaries and/or are in transition, you may still be at risk for developing ovarian cancer, including GCT (risk unknown vs. chronic testosterone use). Your awareness and health matter, and it is extremely important to find compassionate, respectful, gender-supportive care so that you can have regular check-ups. is open to helping FTM transgender individuals manage their ovarian cancer risk.

[The image below includes an example of StopGCT's advanced imaging technical advocacy. It shows the 3D segmentation of a large pelvic GCT (in yellow). StopGCT's advocacy significantly improved this patient's care. Image used with permission.]

What does it mean to be Granulosa Cell Tumor ovarian cancer survivor? From my perspective as a GCT caregiver and avatar,...
06/08/2020

What does it mean to be Granulosa Cell Tumor ovarian cancer survivor? From my perspective as a GCT caregiver and avatar, it means 17 years of fighting for life, information, innovation, awareness and survival, and offering care and comfort to those around me. It is the triumph of every day since diagnosis and the hope and possibility of whatever tomorrow may bring. It also means living with the specter of loss and grief, of pain and uncertainty, and of the voices that have faded around us as we strive to remain strong for the battle ahead. Today is a day to reach for the horizon and celebrate every moment of the journey along the way. For as much as GCT has taken, I am very thankful for the people and purpose it has brought to my life, and for the reminder that the most important thing we can do with every moment is to fight darkness with advocacy and help others stand and meet the dawn. [Photo: “A New Dawning” by Doris C. Metzger]

Recently, I said goodbye to a woman I have known for 30 years. I first met her when I volunteered as a big brother for h...
05/26/2020

Recently, I said goodbye to a woman I have known for 30 years. I first met her when I volunteered as a big brother for her son, Daniel. Big Brothers/Big Sisters told me that it required a minimum 1-year commitment, but after meeting Daniel, I knew it would be for life. It was a pivotal moment that connected all the threads of my future in ways I never could have imagined. Over the years, I became a part of Anne's family and advocated for her throughout her recent cancer diagnosis. Also, it was because of Anne that I found the oncologist that helped me save the life of my partner, Sharon, when she was diagnosed with GCT. And, through the unifying power of Altruism, when GCT ended our hope for children, I realized that I already had a son. Of all the things we choose to do in life, the ones that matter most and that irrevocably change us are those that we do in the human dimension.

This past February and March were very difficult months. Our Knight Family Care Team spent countless hours by Anne's bedside, often around the clock, to honor her wish to fight and to thrive, despite the odds and inevitable progression. And she did. She fought for every possible moment of life, and it was a life that ended far too soon for a woman so vital, caring and generous. Our vigil became more difficult as COVID-19 lock-downs went into place. Cancer doesn't care about social distancing, and it meant that we couldn't be with her at the end of her journey.

It's hard to express what it felt like to be barred from seeing your loved one in her final days and moments of life. I had so many mixed emotions and thoughts - the stress and sense of yielding in comfort care, grief, compassion, anger at injustice, the hope for strength to support those around me (especially Anne's sons), profound relief for her transfiguration and an end to suffering, and ultimately, some measure of mutual peace, giving way to exhaustion and the reflective calm, joy and exploration of memory.

We were allowed to see her, one-at-a-time, as she lay in grace at the end of her life's symphony. For me, it invoked the Adagio from Mahler 9 -- "Sehr langsam und noch zurückhaltend" as I held her hand for the last time. But despite the apparent fait accompli, I was determined to help her extend her life. Anne was a registered organ donor, unfortunately a gift and benefit that terminal cancer usually steals from its host. However, in February, Anne received a brand new pacemaker, something that she could, in fact, donate. So, I looked for and found a great donation program at the University of Michigan, My Heart Your Heart, where they re-purpose used pacemakers to help extend the lives of those who cannot afford them. Initially, neither the hospital nor the mortuary agreed to help the family with this donation. But, after some dedicated advocacy, the hospital agreed to do the extraction and Anne's pacemaker is now waiting to be processed.

The device that kept Anne's heart beating throughout the end of her battle will pay it forward, and, in a manner of speaking, Anne's heart will keep beating for years to come, saving the life of another. It is a gift that is only possible through personal sacrifice and altruism, and is a profound proof-of-life beyond the horizon of cancer.

It is taking time to grieve for Anne, and besides celebrating her life, I am writing this post to reach out to all of you who face the difficulty of having loved ones in care during the COVID-19 lock-down. It was very difficult and frustrating. Don't give in to bureaucracy. Keep advocating in a positive context for whatever safe level of restricted access is possible, be creative in your problem-solving and do all that you can to make the most of whatever shared time you have.

My heart goes out to all of you, and I hope that you are safe and healthy. And, if you are fighting a cancer battle with restricted family access, I hope that you will find a way to be together and to have the support you need and deserve. I will include the information about the pacemaker donation program below in the event that it may be of use. Please pass it on.

Anne Knight of Palo Alto passed away March 25, 2020 following a nearly 3 year battle with cancer. She is survived by her two sons, Ben and Daniel.

StopGCT is very sorry to hear that Terri Nickens Gerace lost her battle with GCT this week. She was a strong GCT advocat...
01/22/2020

StopGCT is very sorry to hear that Terri Nickens Gerace lost her battle with GCT this week. She was a strong GCT advocate and will be missed by all. Condolences to her family and friends.

Celebrate the life of Terri Gerace, leave a kind word or memory and get funeral service information care of Greenoaks Funeral Home.

For the past few weeks, I have been on a care vigil for an unmarried person with advanced cancer who suddenly required h...
10/07/2019

For the past few weeks, I have been on a care vigil for an unmarried person with advanced cancer who suddenly required hospitalization. The long hours in the hospital, especially early on, highlighted all of the challenges that those with cancer and related compromise must endure every step of the way. It also emphasized how important the role of technical advocacy is in care and recovery, given all the issues that can arise during hospitalizations. Our team of 6 close friends and family made sure that someone was present around the clock in conjunction with other hospital sitters. Our vigil made a critical difference in sense of support, quality and timeliness of care, increased physician case focus and also led to a faster recovery and smoother transition to rehab. Research shows that those who are single vs. married may have a smaller support network around them, increased cancer mortality, may be treated with bias by medical professionals and may be less likely to receive the most aggressive treatment. These observations date back to the ‘80s, and in 2013, the Journal of Clinical Oncology (JCO) published the results of a large-scale study entitled “Marital Status and Survival in Patients with Cancer” (https://ascopubs.org/doi/10.1200/JCO.2013.49.6489). In 2018, there was an interesting interview with Dr. Joan DelFattore, Ph.D. of University of Delaware published in NPR (https://www.npr.org/2018/12/09/675139557/why-cancer-treatment-can-differ-for-those-who-arent-married ). And, last month, the NEJM published Dr. DelFattore’s analysis entitled “Death by Stereotype? Cancer Treatment in Unmarried Patients” (https://www.nejm.org/doi/10.1056/NEJMms1902657). You can read about it in the article: “Bias Against Single People Affects Their Cancer Treatment” (https://www.sciencedaily.com/releases/2019/09/190909121243.htm). So, whether or not you have , other , or in general, assemble a strong team that can accompany you to appointments, procedures, and hospitalizations. Your team can watch out for you, support you and, importantly, act on your behalf as your designated medical proxy any time they are needed (assuming you have elected a proxy…and you should!). It is very important that your care providers know that you have a strong network around you so that you will not be subject to any potential treatment bias or neglect when you are at your most vulnerable and so that you will have a chance at the best possible treatment and outcome, no matter what the care setting or phase of treatment might be.

StopGCT has been notified of the grantee for its donation to the CRS at the end of last year. Congratulations to the Dr....
08/30/2019

StopGCT has been notified of the grantee for its donation to the CRS at the end of last year. Congratulations to the Dr. Mary Hitt Lab and Powel Crosley at the University of Alberta! The Société de recherche sur le cancer / Cancer Research Society has awarded a total of CAN$120K (~US$90K), including 50% matching funds, to support 2 years of research for the Hitt Lab proposal entitled "Combination of a novel TRAIL-expressing oncolytic virus with a caspase-3 activator for treatment of granulosa cell tumours." Per the CRS, there was no conflict of interest in the adjudication of this proposal or in the award, and it was highly-ranked among all grant applications. For more information about this donation, please see the earlier posts on our page from Oct/Nov of 2018. See below for the abstract.

Address

1875 S. Bascom Avenue Suite 2400
Campbell, CA
95008

Alerts

Be the first to know and let us send you an email when Stop GCT, Ovarian Cancer Research Foundation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Stop GCT, Ovarian Cancer Research Foundation:

Featured

Share